Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas

scientific article published on July 2001

Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0002-9440(10)61688-4
P932PMC publication ID1850434
P698PubMed publication ID11438469
P5875ResearchGate publication ID11903536

P50authorLars A. AkslenQ11983239
P2093author name stringO Straume
P2860cites workInduction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodiesQ74484401
Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loopsQ74532039
Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to growQ74592128
Mutant p53 correlates with reduced expression of thrombospondin-1, increased angiogenesis, and metastatic progression in melanomaQ74624644
Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinomaQ77349652
Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cellsQ77392041
Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1Q77426354
Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapyQ77555510
Progression-related expression of beta3 integrin in melanomas and neviQ77763337
Angiogenesis is prognostically important in vertical growth phase melanomasQ78062978
Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumoursQ93921697
Adhesive proteins and the hematogenous spread of cancerQ41288940
Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis.Q41295542
Thrombospondin as a regulator of angiogenesisQ41322625
Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.Q41411589
Angiogenesis: new aspects relating to its initiation and control.Q41543929
Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neurogliaQ41677354
Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomasQ41773010
The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thicknessQ42373298
Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesisQ42454817
Thrombospondin-1 and its CSVTCG-specific receptor in wound healing and cancerQ42455654
Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.Q42805124
The constitutive level of vascular endothelial growth factor (VEGF) is more important than hypoxia-induced VEGF up-regulation in the angiogenesis of human melanoma xenograftsQ43202381
Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma studyQ44697724
Angiogenesis during tumor progression in human malignant melanomaQ45818662
Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapyQ46138494
Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progressionQ46439216
Expression of vascular endothelial growth factor in human gastric carcinomasQ47698165
Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas.Q48136880
Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cellsQ48717167
Tumor vascularity as a prognostic indicator in intermediate-thickness (0.76-4 mm) cutaneous melanoma. A quantitative assay.Q50994893
Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase.Q53444387
Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells.Q55476304
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locusQ57269211
Mutations in the CDKN2A ( p16INK4a ) gene in microdissected sporadic primary melanomasQ57664941
Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular densityQ59219543
The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological ActivitiesQ59261168
The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinase and TIMP-2 production in endothelial cellsQ60043731
Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanomaQ67900089
Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progressionQ68547014
Thrombospondin, a potentiator of tumor cell metastasisQ69120538
Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptorsQ70575554
Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expressionQ70786899
Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasisQ70866384
Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGFQ70882002
Beta3 integrin expression in melanoma predicts subsequent metastasisQ71139754
Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1Q71644976
Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell linesQ72721355
Up-regulation of ephrin-A1 during melanoma progressionQ73032207
Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcomaQ73112514
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1Q73308215
Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicityQ73309958
Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanomaQ73803410
Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasisQ73841963
Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivoQ73863756
Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breastQ73872730
p53, vessel count, and vascular endothelial growth factor expression in human colon cancerQ74292646
Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenograftsQ74314875
Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude miceQ74376048
Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosisQ74462138
Angiogenesis correlates with metastasis in melanomaQ74464769
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorQ24294262
The fms-like tyrosine kinase, a receptor for vascular endothelial growth factorQ24328901
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform ExtractionQ25938986
Vascular endothelial growth factor receptor-2-mediated mitogenesis is negatively regulated by vascular endothelial growth factor receptor-1 in tumor epithelial cellsQ28345678
Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1Q28647132
What Is the Evidence That Tumors Are Angiogenesis Dependent?Q29620029
Vasculogenic mimicry and tumor angiogenesisQ30498765
The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.Q33301664
Molecular and biological properties of vascular endothelial growth factorQ33737216
Vasculogenic mimicry: how convincing, how novel, and how significant?Q33832972
Regulation of angiogenesis via vascular endothelial growth factor receptors.Q33833625
Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicryQ33874221
Involvement of integrin alpha V gene expression in human melanoma tumorigenicityQ34222036
Tumor angiogenesis and metastasis--correlation in invasive breast carcinomaQ34570747
Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expressionQ35745301
Regulation of local host-mediated anti-tumor mechanisms by cytokines: direct and indirect effects on leukocyte recruitment and angiogenesisQ35764443
Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological featuresQ35787996
Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomasQ35793483
Tumor vascularity is not a prognostic factor for malignant melanoma of the skinQ35798557
Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical studyQ35831750
Tumor angiogenesis correlates with metastasis in invasive prostate carcinomaQ35833169
Platelet thrombospondin mediates attachment and spreading of human melanoma cellsQ36225286
Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancerQ36292182
Enhanced expression of vascular endothelial growth factor in metastatic melanomaQ36431187
Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expressionQ36431673
Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancerQ36617350
Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomasQ36617389
Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble ratQ36620026
Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomasQ36621924
Immunohistochemical detection of thrombospondin-1 in formalin-fixed, paraffin-embedded tissueQ38477720
Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR.Q40920837
The role of thrombospondin-1 in tumor progression and angiogenesisQ40964893
Regulation of tumor growth and metastasis by thrombospondin-1.Q41073499
Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancerQ41195958
Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.Q41210042
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectmicrovesselQ6840468
endotheliumQ111140
patientQ181600
P304page(s)223-235
P577publication date2001-07-01
P1433published inThe American Journal of PathologyQ4744259
P1476titleExpresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas
P478volume159

Reverse relations

cites work (P2860)
Q46739137A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607).
Q51751812A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanoma.
Q34538284Action of Lovastatin (Mevinolin) on an in vitro model of angiogenesis and its co-culture with malignant melanoma cell lines
Q35146591Angiogenesis, lymphangiogenesis, and melanoma metastasis
Q36346020BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma.
Q57664873BRAF and NRAS Mutations Are Frequent in Nodular Melanoma but Are not Associated with Tumor Cell Proliferation or Patient Survival
Q35234354Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma
Q37020248Blood vessel maturation in human uveal melanoma: spatial distribution of neovessels and mature vasculature
Q80270247Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study
Q39850353Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance
Q44567628Differential expression of vascular endothelial growth factor-A isoforms at different stages of melanoma progression
Q33687242EMMPRIN promotes melanoma cells malignant properties through a HIF-2alpha mediated up-regulation of VEGF-receptor-2.
Q21260421Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma
Q38873842Effects of bisphenol A and 17β-estradiol on vascular endothelial growth factor A and its receptor expression in the non-cancer and cancer ovarian cell lines.
Q52013947Evidence of a bi-phasic effect of thrombospondin-1 on angiogenesis.
Q36014062Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study
Q38431670Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma
Q34678882Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenib
Q38429857Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression
Q36648435Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer
Q30445841High-resolution ultrasound imaging of cutaneous lesions
Q24798737Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer
Q37337431Host deficiency in Vav2/3 guanine nucleotide exchange factors impairs tumor growth, survival, and angiogenesis in vivo
Q50019794Human expression patterns: qualitative and quantitative analysis of thrombospondin-1 under physiological and pathological conditions
Q30475154Imaging of melanoma: usefulness of ultrasonography before and after contrast injection for diagnosis and early evaluation of treatment
Q48138180Immunoexpression of endoglin in brain metastasis secondary to malignant melanoma: evaluation of angiogenesis and comparison with brain metastasis secondary to breast and lung carcinomas
Q47404143Immunohistochemical expression of vascular endothelial growth factor (VEGF) and C-KIT in cutaneous melanocytic lesions
Q60930855Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis
Q42794629Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression
Q33231917Increased laser Doppler flow in skin tumors corresponds to elevated vessel density and reactive hyperemia
Q33355483Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis.
Q33557480Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
Q53500613Loss of BMI-1 expression is associated with clinical progress of malignant melanoma.
Q50791944Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide.
Q38196881Mechanisms of tumour vascularization in cutaneous malignant melanoma: clinical implications
Q49924572Microvessel Density in Patients with Cutaneous Melanoma: An Up-to-Date Systematic Review and Meta-Analysis
Q35065032Molecular pathogenesis and prognostic factors in endometrial carcinoma
Q35747435Molecular profiling of angiogenesis markers.
Q38985288Monoclonal antibodies to murine thrombospondin-1 and thrombospondin-2 reveal differential expression patterns in cancer and low antigen expression in normal tissues
Q34128953Potential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancer
Q40117553Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF.
Q53188381Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma.
Q48760414Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
Q30499036Prognostic value of angiogenesis evaluated with high-frequency and colour Doppler sonography for preoperative assessment of primary cutaneous melanomas: correlation with recurrence after a 5 year follow-up period
Q33665758Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays
Q37385797Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies
Q35157766Remodeling of the microenvironment by aggressive melanoma tumor cells
Q38918913Role of thrombospondin 1 in liver diseases.
Q40655691Role of thrombospondin-1 expression in colorectal liver metastasis and its molecular mechanism.
Q33899574S100A13 is a new angiogenic marker in human melanoma
Q41985319Semaphorin 3E expression correlates inversely with Plexin D1 during tumor progression.
Q41983653Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma
Q40038149The role of VEGF in melanoma progression
Q34997320The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors
Q43103708Thrombospondin-1 expression correlates with angiogenesis in experimental cirrhosis.
Q42835129Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2.
Q37288883Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis
Q33390467Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas
Q44711344Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer
Q52582783Tumour cell expression of interleukin 6 receptor α is associated with response rates in patients treated with sunitinib for metastatic clear cell renal cell carcinoma.
Q30423356VEGFR-2 expression in human melanoma: revised assessment
Q36447447Vascular endothelial growth factor receptor-2 expression is down-regulated by 17beta-estradiol in MCF-7 breast cancer cells by estrogen receptor alpha/Sp proteins
Q35289963Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2.

Search more.